Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 2/20 | 0.53 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.53 |
| ▸ | NAMPT | P43490 | 5/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.48 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.47 |
| ▸ | PLAU | P00749 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3599020 | 0.93 | SMN1; SMN2 (0.57) | SCDSCD5NAMPTSMN1; SMN2ESR2 | |
| SCHEMBL3598199 | 0.93 | NAMPT (0.56) | SCDSCD5NAMPTSMN1; SMN2ESR2 | |
| SCHEMBL3615745 | 0.91 | SCD (0.51) | SCDSCD5NAMPTSMN1; SMN2ESR2 | |
| SCHEMBL3596504 | 0.91 | SMN1; SMN2 (0.57) | SCDSCD5NAMPTSMN1; SMN2ESR2 | |
| SCHEMBL3615748 | 0.91 | SCD (0.53) | SCDSCD5NAMPTSMN1; SMN2ESR2 | |
| SCHEMBL3600477 | 0.91 | NAMPT (0.51) | SCDSCD5NAMPTSMN1; SMN2ESR2 | |
| SCHEMBL3605404 | 0.89 | NAMPT (0.63) | SCDSCD5NAMPTSMN1; SMN2ESR2 | |
| SCHEMBL3605783 | 0.87 | NAMPT (0.56) | SCDSCD5NAMPT | |
| SCHEMBL3606130 | 0.87 | KDM4E (0.50) | SCDSCD5NAMPTSMN1; SMN2ESR2 | |
| SCHEMBL3602755 | 0.86 | SCD (0.51) | SCDSCD5NAMPTSMN1; SMN2ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8487108-B2 | Piperidinyl carbamate intermediates for the synthesis of aspartic protease inhibitors | VITAE PHARMACEUTICALS, INC. (US) | 2013-07-16 | — | — | US | disclosed |
| EP-1966139-B1 | ASPARTIC PROTEASE INHIBITORS | VITAE PHARMACEUTICALS INC (US) | 2011-12-21 | — | — | EP | disclosed |
| US-20100048636-A1 | Aspartic Protease Inhibitors | VITAE PHARMACEUTICALS, INC. | 2010-02-25 | — | — | US | disclosed |
| US-20100041696-A1 | Compounds | SMITHKLINE BEECHAM CORPORATION | 2010-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048636-A1 | Aspartic Protease Inhibitors | DNPEP, PEPD, SERPINB1 | SCD 789/4885SCD5 806/4885NAMPT 1226/4885 |
| US-20100041696-A1 | Compounds | CYP11B2, SCD, CYP3A5 | SCD 2/4885SCD5 4/4885NAMPT 869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.